Arachidonyl-2′-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB1R gene expression and reduces dyskinesias in a rat model of Parkinson's disease

Publication date: Available online 12 May 2020Source: Pharmacology Biochemistry and BehaviorAuthor(s): Melissa Leija-Salazar, Mario Bermúdez de León, Azucena González-Horta, Brenda González-Hernández
Source: Pharmacology Biochemistry and Behavior - Category: Biochemistry Source Type: research